Paiyun Li

发表

DNA hydroxymethylation increases the susceptibility of reactivation of methylated P16 alleles in cancer cells

D. Deng, Xiao Han, Zhao-jun Liu, 2019, Epigenetics.

P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib

D. Deng, Jing Zhou, L. Gu, 2019, bioRxiv.

Hyper expression of MTBP may be an adverse signal for the survival of some malignant tumors

Hongmei Liu, Yuan Tian, Weipeng Liu, 2018, Medicine.

Hydroxymethylated-P16 Allele Is Transcription-Inactive

D. Deng, Xiao Han, Zhao-jun Liu, 2018, bioRxiv.

NOD2 maybe a biomarker for the survival of kidney cancer patients

Hongmei Liu, Yuan Tian, Lili Yu, 2017, Oncotarget.

Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis

Yuan Tian, Juanjuan Song, Bo Pan, 2015, Oncotarget.

Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization

Cuihong Yang, Jianfeng Liu, Zhimou Yang, 2022, Advanced materials.

In Situ Self‐Assembly Supramolecular Antagonist Reinforces Radiotherapy by Inhibiting Tumor Apoptosis Evasion

Fan Huang, Jianfeng Liu, Yumin Zhang, 2023, Advanced Functional Materials.

Driving effect of P16 methylation on telomerase reverse transcriptase-mediated immortalization and transformation of normal human fibroblasts.

Jing Zhou, L. Gu, Baozhen Zhang, 2024, Chinese medical journal.